Cite

HARVARD Citation

    Jones, J. et al. (2018). Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials. British journal of haematology. pp. 504-512. [Online]. 
  
Back to record